Following one of the constants of the Polyclinic Group, its Urology Unit has been equipped in recent years with the most advanced technology to improve the diagnosis and treatment of genitourinary diseases, in men and women.
The latest in detecting prostate cancer: Prostate cancer is the most common cancer in men. In Spain, 33,000 new cases are diagnosed each year, which represents 22% of all cancers that affect the male population. The chances of suffering from it increase as we age, especially from the age of 45, although it is also sometimes diagnosed in young people.
The treatment of kidney stones is performed through minimally invasive techniques using Holmium laser endoscopic lithotripsy.
In addition, the Polyclinic Group will soon acquire a state-of-the-art flexible ureteroscopy to be able to access any kidney stone, regardless of its location. In the future, an extracorporeal shock wave lithotripsy machine will be available to treat certain types of stones without the need for surgical intervention.
At the Laboratory level, the Nuestra Señora del Rosario Polyclinic offers metabolic studies to identify factors that may predispose to the creation of kidney stones as well as studies of the biochemical composition of stones for the preparation of preventive measures.
Polyclinic has a transrectal ultrasound and Prostate Multiparameter Nuclear Magnetic Resonance (NMR) equipment. It is a technique that in recent years has been the maximum technological expression, becoming a key tool for the early diagnosis of prostate cancer, as well as for decision-making in its treatment. MPRM can obtain such accurate images of the prostate that it allows mapping suspicious lesions and establishing the risk of malignant lesions. Once this mapping has been obtained, a biopsy will be carried out in the designated areas.